Drugs / PM10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00502346 | Jul → Nov 2007 | — | Prism Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PM10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00502346 ↗ |
| Known as | PM101 | “The primary objective of the study is to compare the effect of PM101 I.V. administered as an immediate intravenous bolus versus placebo on systolic blood pressure.” NCT00502346 ↗ |
| Route | Intravenous | “immediate intravenous bolus” NCT00502346 ↗ |